Get started
Author

Parnia Geransar

Observed names: P Geransar, P. Geransar
OpenAlex ID: A5081370088
Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials
2018 · Brian G Feagan, William J Sandborn, et al. · Journal of Crohn s and Colitis · 81
Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study
2011 · Mohamed Hassanein, Wasim Hanif, et al. · Current Medical Research and Opinion · 73
Use of teduglutide in adults with short bowel syndrome–associated intestinal failure
2023 · Loris Pironi, Johane P. Allard, et al. · Nutrition in Clinical Practice · 40
Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
2018 · Brian G Feagan, Stefan Schreiber, et al. · Inflammatory Bowel Diseases · 30
PDF
Treatment adherence with vildagliptin compared to sulphonylurea as add-on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan
2013 · W. Hanif, W. Malik, et al. · Current Medical Research and Opinion · 21
Vildagliptin more effectively achieves a composite endpoint of HbA1c<7.0% without hypoglycaemia and weight gain compared with glimepiride after 2 years of treatment
2013 · Giovanni Bader, Parnia Geransar, et al. · Diabetes Research and Clinical Practice · 19
Multi-national observational study to assess quality of life and treatment preferences in patients with Crohn’s perianal fistulas
2023 · Chitra Karki, Amod Athavale, et al. · World Journal of Gastrointestinal Surgery · 18
PDF
Survey of healthcare professionals' experiences of care delivery in patients with chronic intestinal failure: ATLAS of Variance
2023 · Parnia Geransar, Simon Lal, et al. · Clinical Nutrition ESPEN · 16
PDF
Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1
2020 · Edward V Loftus Jr, Bruce E Sands, et al. · Clinical and Experimental Gastroenterology · 15
PDF
P603 INSPIRE: 6-month interim analysis from an observational post-marketing registry on the effectiveness and safety of darvadstrocel in patients with Crohn’s disease and complex perianal fistulas
2022 · O Zmora, D C Baumgart, et al. · Journal of Crohn s and Colitis · 10
Long-Term Effectiveness and Safety of Vedolizumab in Patients with Crohn’s Disease: 5-Year Cumulative Exposure of Gemini 2 Completers Rolling Into the Gemini Open-Label Extension Study
2017 · Severine Vermeire, Edward V. Loftus, et al. · Gastroenterology · 9
Long-Term Effectiveness and Safety of Vedolizumab in Patients with Ulcerative Colitis: 5-Year Cumulative Exposure of Gemini 1 Completers Rolling into the Gemini Open-Label Extension Study
2017 · Edward V. Loftus, Jean Frederic Colombel, et al. · Gastroenterology · 9
Impact of Seton Use on Clinical, Patient-Reported, and Healthcare Resource Utilization Outcomes in Complex Crohn’s Perianal Fistulas: A Systematic Literature Review
2024 · Ian White, Chitra Karki, et al. · Inflammatory Bowel Diseases · 6
Effect of Vedolizumab Treatment on Extraintestinal Manifestations in Patients with Crohn’s Disease: A Gemini 2 Post hoc Analysis
2017 · Brian G. Feagan, William J. Sandborn, et al. · Gastroenterology · 6
P209 Long-term effectiveness and safety of vedolizumab in patients with ulcerative colitis: 5-year cumulative exposure of GEMINI 1 completers rolling into the GEMINI open-label extension study
2017 · E.V. Loftus, J.-F. Colombel, et al. · Journal of Crohn s and Colitis · 6
Epidemiology, treatment patterns, and associated risk factors in perianal fistulizing Crohn’s disease: A systematic literature review
2025 · Caroline McKay, Anna Bolzani, et al. · World Journal of Gastrointestinal Surgery · 5
PDF
DOP019 Effect of vedolizumab treatment on extraintestinal manifestations in patients with Crohn’s disease: a GEMINI 2 post hoc analysis
2017 · B.G. Feagan, W.J. Sandborn, et al. · Journal of Crohn s and Colitis · 5
Management of Perianal Fistulas Associated with Crohn Disease
2024 · Kay Greveson, Ola Haj, et al. · Gastroenterology Nursing · 4
DOP021 Long-term effectiveness and safety of vedolizumab in patients with Crohn's disease: 5-year cumulative exposure of GEMINI 2 completers rolling into the GEMINI open-label extension study
2017 · S. Vermeire, E.V. Loftus, et al. · Journal of Crohn s and Colitis · 3
DOP026 Sustained remission with vedolizumab in patients with moderately to severely active ulcerative colitis: a GEMINI 1 post hoc analysis of week 14 remitters
2017 · A. Stallmach, B. Bokemeyer, et al. · Journal of Crohn s and Colitis · 2
Atlas of variance: evaluation of care delivery to patients with chronic intestinal failure in Europe; a focus on home parenteral nutrition
2021 · S. Lal, S.M. Schneider, et al. · Clinical Nutrition ESPEN · 1
P738 Sustained clinical remission with vedolizumab in Moderate-to-Severe Crohn’s disease: A GEMINI 2 post hoc analysis of Week 14 remitters
2018 · R Hardi, B Bokemeyer, et al. · Journal of Crohn s and Colitis · 1
Real life effectiveness and safety of vildagliptin compared with other OADs in European type 2 diabetes mellitus patients: results from the EDGE study
2014 · PM Nilsson, Helmut Brath, et al. · Diabetologia · 1
A UK retrospective observational survey of vildagliptin as add-on antidiabetes therapy in elderly patients
2011 · Mukesh Mistry, Nicola Lister, et al. · The British Journal of Diabetes · 1
P887 Epidemiology of perianal fistulising Crohn’s disease: a systematic literature review
2023 · C McKay, S Pacis, et al. · Journal of Crohn s and Colitis
PDF
Works count: 38
Citation count: 382
H-index: 10
I10-index: 10
Year
Topic
Type